Meet the specialists: COVID-19 vaccine for cancer patients Q&A

29th January 2021

Missed our free GatewayC LIVE webinar? Watch our recording here.

In this webinar, GatewayC met Professor Robert Duncombe, Director of Pharmacy at The Christie NHS Foundation Trust and Dr Neil Bayman, Consultant Clinical Oncologist and Associate Medical Director at The Christie NHS Foundation Trust.

Our speakers answered key questions from our audience, which included:

  1. Can patients receiving chemotherapy have the vaccine?
  2. Where are patients receiving the vaccine?
  3. Will cancer inpatients receive vaccinations?
  4. Do we advise patients who have had severe taxol reactions to avoid the Pfizer vaccine?
  5. How (as GPs) are we going to know if someone is clinically vulnerable or about to start treatment?

Find out more:

  • Access GatewayC’s full webinar library here
  • Watch this recorded webinar here
  • Access GatewayC’s Managing Physical Effects course here

Follow us: LinkedIn | Twitter | Facebook

Latest from the Blog

Cancer Keys: Oesophageal cancer and dysphagia

Cancer Keys: Oesophageal cancer and dysphagia

Potential pitfall: Dysphagia is the most common presenting symptom of oesophageal cancer. It should be considered alongside a number of other symptoms when contemplating an upper gastrointestinal cancer referral. Helpful hint: NICE NG12 guidelines recommend offering...

read more
4 Tips to Manage Barrett’s Oesophagus

4 Tips to Manage Barrett’s Oesophagus

Thursday 4th March 2021 Barrett's oesophagus is associated with an increased risk of oesophageal cancer. When supporting a patient with Barrett’s oesophagus, are you clear on how to manage the condition? 4 tips to manage Barrett’s oesophagus in primary care include:...

read more

Related Posts

NEW COURSE: Oesophageal Cancer – Early Diagnosis

NEW COURSE: Oesophageal Cancer – Early Diagnosis

Thursday 25th February 2021 We are delighted to announce that the new Oesophageal Cancer - Early Diagnosis course is now available on GatewayC. Oesophageal cancer is the 14th most common cancer in the UK, accounting for 3% of all new cancer cases with the highest...

read more
Assessing peripheral neuropathy

Assessing peripheral neuropathy

Thursday 18th February 2021 It is important for primary care practitioners to explore and assess peripheral neuropathy carefully by evaluating the level of impact on the patient, both physically and emotionally. Many individuals receiving chemotherapy are nervous...

read more